NuCicer

NuCicer produces chickpeas using proprietary plant breeding technologies, developing non-GMO, high-protein chickpea varieties that enable farmers to offer enhanced products throughout the agri-food supply chain. Founded in 2019 and headquartered in Davis, United States, NuCicer has raised approximately $25.3M in Series A funding from investors including Leaps by Bayer, Bayer, Blue Horizon, Lever VC, Illumina Ventures, Rhapsody Venture Partners, and The House Fund. The company employs 25 people and uses advanced genomic selection and breeding techniques to develop chickpea varieties with significantly higher protein content and improved agronomic traits, addressing the growing demand for plant-based protein ingredients. NuCicer's high-protein chickpeas offer food manufacturers a sustainable, non-allergenic protein source that can improve the nutritional profile and cost-effectiveness of plant-based food products while supporting regenerative agriculture through chickpea's natural nitrogen-fixing capabilities.